Phibro Animal Health Corporation has announced that its shareholders have agreed to sell a private placement of 19.5 per cent of common shares, for USD52.7m, to 3i Quoted Private Equity, i
Phibro Animal Health Corporation has announced that its shareholders have agreed to sell a private placement of 19.5 per cent of common shares, for USD52.7m, to 3i Quoted Private Equity, in compliance with Regulation S. This investment company, listed on the London Stock Exchange, is a subsidiary of private equity concern 3i.
Phibro also announces its intention to offer its common shares to non-U.S. persons via admission to the London Stock Exchange’s Alternative Investment Market, also in compliance with Regulation S. If completed, following the institutional offering on Aim, current Phibro shareholders would hold approximately 70 per cent of the common shares of the company with the remainder being held by 3i QPE and other institutional investors.
The securities which may be offered by the selling shareholders and Phibro will not be and have not been registered under the United States Securities Act of 1933, as amended, and the securities may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the United States federal securities laws.
This document does not constitute or form part of any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any securities of Phibro or an invitation or inducement to engage in investment activity in any jurisdiction, nor will it or any part of it or the fact of its distribution form the basis of, or be relied on in connection with, any contract thereof.
Phibro is a diversified global manufacturer and marketer of a broad range of animal health and nutrition products to the poultry, swine and cattle markets. Phibro is also a manufacturer and marketer of performance ingredients for ethanol production, wood preservation and personal care products.
3i Quoted Private Equity is a Jersey-incorporated, public closed-end investment company whose shares are listed on the London Stock Exchange’s main market for listed securities. Its strategy is to invest in quoted companies where it can introduce private equity techniques and methodologies. 3i QPE is advised in its investments by 3i Investments (a wholly-owned subsidiary of 3i Group). It raised around GBP400m at its initial public offer last year.
